Climacteric

Aims & Scope

Climacteric is the official journal of the International Menopause Society (IMS).

As an international peer-reviewed journal it publishes original research and reviews of all aspects of aging in women.

Climacteric was founded by the IMS in 1998 and today has become a leading journal in the publication of peer-reviewed papers on the menopause, climacteric and mid-life health.

Topics covered include endocrine changes, symptoms attributed to the menopause and their treatment, hormone replacement and alternative therapies, lifestyles, and the counselling and education of peri- and postmenopausal women.

Climacteric, published bimonthly, also features regular invited reviews, editorials and commentaries on recent developments.

The editorial review board of Climacteric includes leading scientific and clinical experts in the field of midlife medicine and research and is headed by its Editor-in-Chief, Professor Rod Baber of Australia.

He and his team of Associate Editors act independently to set a clear editorial policy, co-ordinate peer review, and ensure a rapid response to submitted papers.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.2
2024	2.90

Journal Rank

Year	Value
2024	5895

Journal Citation Indicator

Year	Value
2024	819

SJR (SCImago Journal Rank)

Year	Value
2024	0.879

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	88

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy

  Citation: 736

  Authors: R. J., N., A.

• Pharmacology of estrogens and progestogens: influence of different routes of administration

  Citation: 619

  Authors: H

• Understanding weight gain at menopause

  Citation: 448

  Authors: S. R., C., P., M. A., R. E., D., P.

• Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging

  Citation: 414

  Authors: Siobán D., Margery, Janet E., Roger, Pauline, Robert W., Sherry, Patrick M., Tobie J.

• Recommendations for the management of postmenopausal vaginal atrophy

  Citation: 404

  Authors: D. W., N.

• Long-term health consequences of premature or early menopause and considerations for management

  Citation: 398

  Authors: S. S., C. L., L. T., W. A.

• The prevalence of urinary incontinence

  Citation: 357

  Authors: I., M.

• Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey

  Citation: 346

  Authors: R. E., M.

• Menopause and cardiovascular disease: the evidence

  Citation: 339

  Authors: G. M. C., C., G., M.

• Executive summary: Stages of Reproductive Aging Workshop (STRAW)

  Citation: 328

  Authors: M. R., S., E., R., N., W., N.

---